Cargando…

Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal

OBJECTIVE: To describe and analyze the predictive models of the prognosis of patients with hepatocellular carcinoma (HCC) undergoing systemic treatment. DESIGN: Systematic review. DATA SOURCES: PubMed and Embase until December 2020 and manually searched references from eligible articles. ELIGIBILITY...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Li, Li, Xiaomi, Li, Wendong, Ding, Xiaoyan, Zhang, Yongchao, Chen, Jinglong, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270753/ https://www.ncbi.nlm.nih.gov/pubmed/35810271 http://dx.doi.org/10.1186/s12885-022-09841-5

Ejemplares similares

Development of a Multivariate Prognostic Model for Lenvatinib Treatment in Hepatocellular Carcinoma
por: Li, Xiaomi, et al.
Publicado: (2023)

Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma
por: Li, Xiaomi, et al.
Publicado: (2022)

Treatment options for unresectable hepatocellular carcinoma with hepatitis virus infection following sorafenib failure
por: Li, Xiaomi, et al.
Publicado: (2022)

A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus
por: Li, Xiaomi, et al.
Publicado: (2023)

Clinical study of lenvatinib in the treatment of hepatitis virus-related hepatocellular carcinoma and antiviral therapy
por: Li, Xiaomi, et al.
Publicado: (2023)

Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA
por: Shen, Yanjun, et al.
Publicado: (2019)

A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma
por: Teng, Ying, et al.
Publicado: (2022)

Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation
por: Shen, Yanjun, et al.
Publicado: (2019)

Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023)

Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
por: Pan, Jen-Jung, et al.
Publicado: (2010)

Prognostic prediction models for oropharyngeal squamous cell carcinoma (OPSCC): a protocol for systematic review, critical appraisal and meta-analysis
por: Lu, Zhen, et al.
Publicado: (2023)

Critical appraisal of TNM versus HKU staging system for postoperative prognostic evaluation of hepatocellular carcinoma
por: She, Wong Hoi, et al.
Publicado: (2021)

Incidence and risk of hypertension with lenvatinib in treatment of solid tumors: An updated systematic review and meta‐analysis
por: Wu, Hongxiao, et al.
Publicado: (2022)

Risk prediction models for esophageal cancer: A systematic review and critical appraisal
por: Li, He, et al.
Publicado: (2021)

Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma
por: Cozzi, Luca, et al.
Publicado: (2018)

Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
por: Ansari, Jawaher, et al.
Publicado: (2013)

Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma
por: Chen, Shanshan, et al.
Publicado: (2022)

Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study
por: Ding, Xiaoyan, et al.
Publicado: (2020)

Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting—A Multi-Center Observational Study
por: Ding, Xiaoyan, et al.
Publicado: (2022)

Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma
por: Sun, Wei, et al.
Publicado: (2021)

Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal
por: Espejo-Cruz, María Lola, et al.
Publicado: (2021)

Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence
por: Koh, Ye Xin, et al.
Publicado: (2018)

Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4
por: Qin, Shukui, et al.
Publicado: (2017)

Gene signature to predict prognostic survival of hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2022)

Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal
por: Bellou, Vanesa, et al.
Publicado: (2019)

Reporting and Methods in Developing Prognostic Prediction Models for Metabolic Syndrome: A Systematic Review and Critical Appraisal
por: Zhang, Hui, et al.
Publicado: (2020)

Multidisciplinary Management of Patients with Unresectable Hepatocellular Carcinoma: A Critical Appraisal of Current Evidence
por: Gholam, Pierre M., et al.
Publicado: (2019)

Early Prediction of Objective Response of Fibrinogen in a Real-World Cohort of Hepatocellular Carcinoma Cases Treated by Programmed Cell Death Receptor-1 and Lenvatinib
por: Shen, Yanjun, et al.
Publicado: (2021)

Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma
por: Bukowski, Ronald M
Publicado: (2011)

Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE
por: Li, Yuxuan, et al.
Publicado: (2023)

Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis
por: Li, De-Zhao, et al.
Publicado: (2022)

Prediction Models for Prognosis of Cervical Cancer: Systematic Review and Critical Appraisal
por: He, Bingjie, et al.
Publicado: (2021)

Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib
por: Hsieh, Ming-Han, et al.
Publicado: (2020)

The Prognostic Role of Circulating FPR Before Operation in Patients with BCLC A-C Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Shen, Yanjun, et al.
Publicado: (2022)

Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
por: Cao, Guangchao, et al.
Publicado: (2015)

Prognostic models predicting transition to psychotic disorder using blood-based biomarkers: a systematic review and critical appraisal
por: Byrne, Jonah F., et al.
Publicado: (2023)

Machine learning in vascular surgery: a systematic review and critical appraisal
por: Li, Ben, et al.
Publicado: (2022)

Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma
por: Ye, Ding-Wei, et al.
Publicado: (2014)

HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma
por: Qi, Xiaolong, et al.
Publicado: (2016)

Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis
por: Li, Shuangshuang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8kjte9007guore14th0p39b1jh